FHTX Foghorn Therapeutics Inc.
$2.05▲ +0.00%
Healthcare
Other
After hours
$2.05▲ +0.00%
Oct 27, 4:01 PM ET
Volume 874.7K
Avg Volume (10D) 636.4K
Key Metrics & Fundamentals
Market Cap
$121.74M
P/E Ratio
–
Div Yield
0.00%
52W Range
1.79 - 7.61
% vs 50 MA
-47.35%
% vs 200 MA
-57.06%
RSI-14
27.2
MACD Histogram
+0.1200
Beta (1Y vs SPY)
1.58
Free Cash Flow
-$17.89M
Gross Rev
$16.07M
Gross Profit
$16.07M
EBITDA
-$8.58M
COGS
–
Operating Exp
$24.88M
Operating Income
-$8.81M
EBIT
-$8.81M
Pretax Income
-$7.19M
Net Income
-$7.19M
EPS (Diluted)
-0.10
Price & Volume History
Loading chart…
Recent News
Could You Have Seen The Run In Kymera Stock Coming?
Trefis · Oct 26, 2026 5:34 PM ET
Foghorn Therapeutics (FHTX) Stock Fair Value Moves Lower After Pipeline And Lilly Reset
Simply Wall St. · Oct 21, 2026 9:24 PM ET
Evercore ISI Downgrades Foghorn Therapeutics to In Line, $3 Price Target
MT Newswires · Oct 13, 2026 7:33 AM ET
Foghorn Therapeutics Shares Fall After Wedbush Downgrade
MT Newswires · Oct 2, 2026 2:43 PM ET
Top Midday Decliners
MT Newswires · Oct 2, 2026 2:29 PM ET
FHTX Stock Extends Sell-Off After Lilly Collaboration Ends — Wedbush Slashes Target By 80%
Stocktwits · Oct 2, 2026 2:12 PM ET
Foghorn Therapeutics layoffs after Eli Lilly ends cancer deal
Quartz · Oct 2, 2026 9:50 AM ET
Correction: Top Midday Decliners
MT Newswires · Oct 2, 2026 8:22 AM ET
Wedbush Downgrades Foghorn Therapeutics to Neutral From Outperform, Cuts Price Target to $2 From $10
MT Newswires · Oct 2, 2026 7:10 AM ET
TD Cowen Downgrades Foghorn Therapeutics to Hold From Buy
MT Newswires · Oct 2, 2026 6:00 AM ET
Financial Overview - Income Statement
Quarterly
Jun 2026
See FHTX's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.